COVID-19住院时肺栓塞患病率及预测评分与家庭治疗的作用
本文回应Porfidia等对原研究的关注,原研究描述COVID-19患者入院时肺栓塞(PE)患病率。作者同意入院时需考虑PE诊断流程,因 indiscriminate 执行CTPA不可行。原文提及尽管临床怀疑度低,入院时PE患病率高。
要点
- COVID-19患者入院时PE患病率高,但临床怀疑度低。
- 入院时需考虑PE诊断算法,避免常规 indiscriminate CTPA。
- 预测评分与家庭治疗在PE诊断路径中的角色需进一步明确。
核心结论
- COVID-19患者入院时尽管临床怀疑度低,肺栓塞患病率仍高。
- 入院时需考虑PE诊断算法, indiscriminate CTPA不可行。
主要发现
- COVID-19患者入院时肺栓塞患病率高,而临床怀疑水平低。
临床怎么用
- 对COVID-19入院患者应考虑PE诊断算法,避免常规 indiscriminate 行CTPA。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is a high prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission despite a low level of clinical suspicion https://bit.ly/3ungLrQ We thank A. Porfidia and co-workers for their interest in our study describing the prevalence of pulmonary embolism (PE) in patients with coronavirus disease 2019 (COVID-19) at the time of hospital admission [1]. We fully agree on the need to consider a PE diagnostic algorithm in COVID-19 at the time of hospital admission, because indiscriminate execution of computed tomography pulmonary angiography (CTPA) cannot be a workable, routine approach in such patients.
引用
- Jevnikar M, Sanchez O, Humbert M, et al. Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment. Eur Respir J. 2021. PMID: 33986033. doi:10.1183/13993003.01033-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。